Product Information
ZEMBRACE SYMTOUCH 3 MG/0.5 ML is a brand product labeled by Upsher-Smith Laboratories LLC, priced at $384.0892 per ML under NDC 00245080938. Its NADAC has been published 196 times since May 5, 2021.
FDA first approved this application on Jan 28, 2016.
The High Outlier badge above means this manufacturer's average price in the Sumatriptan Succinate market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
3 mg/1
Manufacturer
Upsher-Smith Laboratories LLCNDC
00245080938
Classification
Brand
Dosage Form
INJECTION, SOLUTION
Route
SUBCUTANEOUS
Effective Date
9/23/2026
Active Ingredients
SUMATRIPTAN SUCCINATEApproval Type
New Drug (NDA)
FDA Application
NDA208223FDA Approved
1/28/2016
On Market Since
2/22/2016
Pharmacological Classes
Price Statistics
The NADAC for ZEMBRACE SYMTOUCH 3 MG/0.5 ML has been published 196 times since May 5, 2021, and over the history we have for it it has risen 16.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $384.0892 per ML |
|---|---|
| All-time high | $384.6373 (Apr 15, 2026) |
| All-time low | $330.2767 (May 5, 2021) |
| 52-week high | $384.6373 |
| 52-week low | $381.4340 |
| Median price | $383.0348 |
| Average price | $365.2289 |
| Largest weekly change | +7.8% (Feb 21, 2024) |
| Weeks tracked | 196 |
| Tracking since | May 5, 2021 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Sumatriptan Succinate market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Upsher-Smith Laboratories LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Sumatriptan Succinate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Serotonin-1b and Serotonin-1d Receptor Agonist class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of ZEMBRACE SYMTOUCH 3 MG/0.5 ML?
The current National Average Drug Acquisition Cost (NADAC) for ZEMBRACE SYMTOUCH 3 MG/0.5 ML, manufactured by Upsher-Smith Laboratories LLC, is $384.0892 per ML (NDC 00245080938), effective Sep 30, 2026.
How has the price of ZEMBRACE SYMTOUCH 3 MG/0.5 ML changed over time?
Over the history we have for it, the NADAC for ZEMBRACE SYMTOUCH 3 MG/0.5 ML has risen 16.3%. It has been tracked across 196 weekly CMS publications since May 5, 2021.
What are the highest and lowest recorded NADAC prices for ZEMBRACE SYMTOUCH 3 MG/0.5 ML?
Since May 5, 2021, the NADAC for ZEMBRACE SYMTOUCH 3 MG/0.5 ML has ranged from a low of $330.2767 (May 5, 2021) to a high of $384.6373 (Apr 15, 2026), with a median of $383.0348 per ML.
Are there cheaper alternatives to ZEMBRACE SYMTOUCH 3 MG/0.5 ML?
No other NADAC-published product currently shares the active ingredient and strength of ZEMBRACE SYMTOUCH 3 MG/0.5 ML in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures ZEMBRACE SYMTOUCH 3 MG/0.5 ML?
ZEMBRACE SYMTOUCH 3 MG/0.5 ML (NDC 00245080938) is labeled by Upsher-Smith Laboratories LLC, and CMS classifies it as a brand product.